Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vaxart Inc | VXRT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.0156 | -3.91% | 0.3834 | 0.42 | 0.37 | 0.40 | 0.399 | 23:59:43 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.3592 | 0.45 | 0.0908 | 20.18% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 524 | 243,420 | $ 0.3969867 | $ 96,635 | 522,329 | 0.2543 - 5.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:58:17 | 99 | $ 0.37 | USD |
Vaxart Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 18.30M | 47.72M | $ -18.01M | -2.34 | - | 44.97M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Vaxart News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VXRT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.355 | 0.42 | 0.342 | 0.3815016 | 510,628 | 0.0284 | 8.0% |
| 1 Month | 0.31 | 0.42 | 0.283 | 0.3545027 | 448,068 | 0.0734 | 23.68% |
| 3 Months | 0.3332 | 0.42 | 0.266 | 0.342645 | 388,383 | 0.0502 | 15.07% |
| 6 Months | 0.72 | 0.7798 | 0.2543 | 0.3874281 | 510,741 | -0.3366 | -46.75% |
| 1 Year | 2.15 | 5.00 | 0.2543 | 1.04 | 545,243 | -1.77 | -82.17% |
| 3 Years | 16.17 | 16.50 | 0.2543 | 3.83 | 379,130 | -15.79 | -97.63% |
| 5 Years | 29.04 | 31.02 | 0.2543 | 5.56 | 251,396 | -28.66 | -98.68% |
Vaxart Description
| Vaxart Inc is a biopharmaceutical company. It is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The company has three product candidates which are; vapendavir, an oral treatment for human rhinovirus (HRV) upper respiratory infections in moderate-to-severe asthmatics; BTA585, an oral fusion protein inhibitor for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in for condyloma caused by human papillomavirus. |
